| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $25.0M | — | +3.4% |
| SG&A Expense | $5.9M | — | -52.5% |
| Operating Income | -$30.9M | — | +15.6% |
| Income Tax | $0 | — | — |
| Net Income | -$27.8M | — | +13.0% |
| EPS (Basic) | -$0.37 | — | +14.0% |
| EPS (Diluted) | -$0.37 | — | +14.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.4M | -31.0% | -48.0% |
| Short-term Investments | $203.1M | -14.2% | -4.6% |
| Current Assets | $235.9M | -16.5% | -13.1% |
| Total Assets | $372.1M | -8.0% | -20.9% |
| Current Liabilities | $18.2M | -18.2% | -2.9% |
| Total Liabilities | $86.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$28.2M | — | +4.8% |
| Capital Expenditures | $413K | — | -20.3% |
| Investing Cash Flow | $15.9M | — | -70.7% |
| Financing Cash Flow | $6K | — | — |
| Free Cash Flow | -$28.6M | — | +5.0% |
| -6.1% |
| Stockholders' Equity | $285.9M | -8.5% | -24.5% |